Actafarma Laboratories introduces its musculoskeletal line extension to the network of health professionals specialist in trauma and orthopedics: Movial IMC. This innovative food supplement is focused on the treatment of osteoarthritis and other joint diseases in overweight or obese patients.
Its results are supported by clinical studies demonstrating its effectiveness in the treatment of metabolic arthritis, published in scientific journals such as Rheumatology International.
This congress organized by the SECOT, will bring together the most significant industry professionals, specialized in trauma and orthopedic surgery. This year additionally, it has the participation of AEETO (Spanish Association of Nursing in Trauma and Orthopaedics).
In pursuit of Laboratories Actafarma to convey to the health care community the scientific advances in their therapeutic lines, the laboratory has promoted participation in this conference with a training stand. Specialists and physicians will have a wide range of training during the three-day congress, having the opportunity to access the clinical study results for Movial IMC and know its scientific support and application possibilities in patients, directly shown by the Technical Department of the Laboratory.